Emyr Lloyd-Evans

Title: Emyr Lloyd-Evans: Innovator in Phosphorus Derivatives

Introduction

Emyr Lloyd-Evans is a notable inventor based in South Glamorgan, GB. He has made significant contributions to the field of medicinal chemistry, particularly in the development of phosphorus derivatives. His work focuses on creating compounds that have therapeutic potential for various lysosomal storage disorders.

Latest Patents

Emyr holds a patent for "Phosphorodiamidates and other phosphorus derivatives of fingolimod and related S1P receptor modulators." This patent describes compounds of general formula (I), wherein specific groups are defined as inhibitors of class I histone deacetylases. These compounds are particularly useful in treating lysosomal storage disorders, especially Niemann-Pick type C disease, as well as other related conditions such as defective autophagy, accumulation of free cholesterol, and mycobacterial diseases. He has 1 patent to his name.

Career Highlights

Emyr is affiliated with University College Cardiff Consultants Limited, where he applies his expertise in medicinal chemistry. His innovative work has the potential to impact the treatment of serious health conditions, showcasing his commitment to advancing medical science.

Collaborations

Emyr has collaborated with notable colleagues, including Fabrizio Pertusati and Edward James. Their combined efforts contribute to the advancement of research in the field of medicinal chemistry.

Conclusion

Emyr Lloyd-Evans is a distinguished inventor whose work in phosphorus derivatives holds promise for treating lysosomal storage disorders. His contributions to medicinal chemistry are noteworthy and reflect his dedication to improving health outcomes through innovation.